Skip to main content

Table 2 Multivariate analysis of risk factors of chemo-resistance among endometriosis related ovarian cancer patients

From: Clinical analysis of chemo-resistance risk factors in endometriosis associated ovarian cancer

  B S.E. P OR(95%CI)
Age .337 .395 .393 1.4(0.65~ 3.04)
Bloating −.057 .401 .886 0.94(0.43~ 2.07)
Emaciation 1.447 .791 .067 4.25(0.9~ 20.02)
Ca125 in normal range .728 .797 .361 2.07(0.43~ 9.87)
EM −.016 .573 .978 0.98(0.32~ 3.03)
FIGO stagea 1.422 .497 .004* 4.15(1.57~ 10.97)
LN metastasis .980 .477 .040* 2.66(1.05~ 6.78)
LN dissection 1.059 .440 .016* 2.88(1.22~ 6.82)
Residual disease .396 .405 .328* 1.49(0.67~ 3.29)
Breast cancer 1.851 .918 .044* 6.37(1.05~ 38.49)
Constant −5.388 1.018 .000  
  1. *The difference reached statistical significance. P values were cultivated by Cox regression analysis. The overall test of the above model showed the model was significance, p < 0.0001
  2. aAccording to the classification system of FIGO staging (2013 version)
  3. Abbreviation: Ca125 cancer antigen 125, EM endometriosis, LN lymph node